Discover
MLYS
Mineralys Therapeutics, Inc.
26.89
2 x 20.09
2 x 34.20
bid
ask
-
0.09
0.33%
2 @ 04:00 PM
26.89 +0.00 (0.00%)
| Ytd | -25.90% | |
| 1y | 96.28% |
26.63
day range
27.93
12.59
52 week range
47.65
| Open | 26.72 | Prev Close | 26.98 | Low | 26.63 | High | 27.93 | Mkt Cap | 2.37B |
| Vol | 1.34M | Avg Vol | 1.58M | EPS | -1.97 | P/E | N/A | Forward P/E | -12.83 |
| Beta | 0.56 | Short Ratio | 4.41 | Inst. Own | 107.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 27.21 | 200-d Avg | 32.72 | 1yr Est | 49.00 |
MLYS News
benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
Reported Sunday, Mineralys Therapeutics Presents Late-Breaking Data At ENDO 2026 Showing Lorundrosta
– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a prot
benzinga.com
Mineralys to Present New Trial Data at ENDO 2026, Proteomic Analysis Selected for Late-Breaking ENDO
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a biopharmaceutical company focused on developing medici
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
Mineralys Prices $150M Stock Offering Of 5.66M Shares At $26.50/Share, To Use Share Sale Proceeds fo
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a biopharmaceutical company focused on developing medici